ទំព័រដើម › មហារីកទ្រូង › ហ្វ្លរីដា › Tampa
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកទ្រូង នៅក្នុង Tampa, FL
ការសិក្សាចំនួន 43 សម្រាប់ មហារីកទ្រូង កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Tampa (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Moffitt Cancer Center, Tampa
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
Study of AVZO-021 in Patients With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Clinical Trial Site, Tampa
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
កំពុងជ្រើសរើសដំណាក់កាល 1
- Moffitt, Tampa
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Moffitt, Tampa
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center, Tampa
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
កំពុងជ្រើសរើសដំណាក់កាល 3
- Moffitt Cancer Center, Tampa
Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Moffitt Cancer Center, Tampa
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Moffitt Cancer Center, Tampa
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Moffitt Cancer Center-McKinley Campus, Tampa
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Moffitt Cancer Center, Tampa
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
កំពុងជ្រើសរើសដំណាក់កាល 3
- Moffitt Cancer Center, Tampa
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Moffitt Cancer Center, Tampa
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Moffitt Cancer Center, Tampa
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Moffitt Cancer Center, Tampa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
ILR to Prevent BRCL_MCC 23608
កំពុងជ្រើសរើស
- Tampa General Hospital, Tampa
- Moffitt Cancer Center, Tampa
- University of South Florida, Tampa
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
កំពុងជ្រើសរើសដំណាក់កាលដំបូង ១
- Moffitt Cancer Center, Tampa
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Moffitt Cancer Center, Tampa
The MIND-BC Study: MIND Diet for Breast Cancer Cognition
កំពុងជ្រើសរើស
- Moffitt Cancer Center, Tampa
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- St. Joseph's Women's Hospital, Tampa
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Moffitt Cancer Center, Tampa
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Massive Bio SYNERGY-AI site, Tampa
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
កំពុងជ្រើសរើសដំណាក់កាល 3
- Moffitt Cancer Center, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Exelixis Clinical Site #16, Tampa
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- St. Joseph's Hospital - Baycare, Tampa
- University of South Florida, Tampa
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Moffitt Cancer Center, Tampa
ការសាកល្បងសម្រាប់ មហារីកទ្រូង នៅក្នុងទីក្រុងផ្សេងទៀត
- New York City, NYការសិក្សា 136
- Houston, TXការសិក្សា 126
- Boston, MAការសិក្សា 112
- Nashville, TNការសិក្សា 81
- Los Angeles, CAការសិក្សា 73
- Edison, NJការសិក្សា 68
- St. Louis, MOការសិក្សា 64
- Queens, NYការសិក្សា 64
- Durham, NCការសិក្សា 64
- Chicago, ILការសិក្សា 59
- Philadelphia, PAការសិក្សា 56
- Dallas, TXការសិក្សា 55
ការសិក្សាផ្សេងទៀតនៅក្នុង Tampa
- Non-Small Cell Lung Cancerការសិក្សា 51
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 39
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 34
- ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ការសិក្សា 29
- មហារីកដែលរីករាលដាលការសិក្សា 29
- មហារីកសួតការសិក្សា 29
- មហារីកតំបក់ការសិក្សា 26
- មហារីកស៊ុតការសិក្សា 21
- មេឡាណូម៉ាការសិក្សា 19
- ជំងឺ Myelodysplastic Syndromesការសិក្សា 19
- មហារីកតូចការសិក្សា 18
- បេះដូងខ្សោយការសិក្សា 18
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។